ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645431 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645431; 2) Community: the network communities that were significantly associated with the response to NSC 645431; 3) Molecule: the relationships between components within communities and NSC 645431; 4) MDR: the compounds that were significantly associated with the NSC 645431.

NSC Compound Enrichment Correlation
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0462077035966088 0.35196193
NSC 179945 1H-Pyrazole-1-ethanol, 4,4'-azoxybis[3,5-dimethyl- 0.0462077035966088 0.38638251
NSC 215721 Null 0.0462077035966088 0.31608252
NSC 343499 CI-921: amsacrine derivative 0.0462077035966088 0.11123749
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 0.0462077035966088 0.29698652
NSC 610457 Camptothecin Derivative 0.0462077035966088 0.23193157
NSC 624166 Null 0.0462077035966088 0.43231669
NSC 624358 Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- 0.0462077035966088 0.32055365
NSC 628562 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-diphenyl- 0.0462077035966088 0.24335277
NSC 643845 Null 0.0462077035966088 0.2628829
Total:61  Current:57    [First] [Prev] [Next] [Last]